Clinical Trial Results: Safety and Activity of PolyPEPI1018 Plus Atezolizumab in Colorectal Cancer. [Phase 2]

View source ↗

Summary

Phase 2 trial assessing safety and activity of PolyPEPI1018 in combination with atezolizumab in metastatic colorectal cancer completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Atezolizumab (atezolizumab)
• PolyPEPI1018 (PolyPEPI1018)

Snippet

Sponsor: Treos Bio Limited | Conditions: Colorectal Cancer Metastatic | Phase 2 | Status: COMPLETED | Results posted: 2026-08-07